The DIA has announced that its early registration fee reduction for next month's EuroMeeting will end on Tuesday February 11.
The DIA has announced that its early registration fee reduction for next month’s EuroMeeting will end on Tuesday February 11. The standard member’s registration for the meeting will rise from 1700 euros to 1850 euros after February 11, according to the organizers.
Also, a new co-chair has been appointed for the congress: Christa Wirthumer-Hoche, who recently became Head of the Austrian Medicines Agency.
The conference will take place in Vienna, Austria, from 25 to 27 March 2014. It is likely to attract over 3,000 delegates from more than 50 countries. It brings together professionals from the biopharmaceutical industry, contract research and service organizations, academic research centers, regulatory agencies and health ministries, as well as delegates from patient organizations.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.